Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiovascular Disease
Study examines role of insulin resistance in predicting cardiovascular disease
September 27th, 2004
The European Group for the study of Insulin Resistance (EGIR) announced that the clinical trial recruitment milestone of 1,200 subjects has been reached in the Relationship between Insulin Sensitivity and Cardiovascular disease risk (RISC) study. RISC is the largest study using the euglycaemic clamp technique to date to examine whether insulin resistance predicts cardiovascular disease (CVD), as well as future development of type 2 diabetes. This study, cosponsored by the European Union (E.U.) and AstraZeneca, began in February 2002, involves 14 European countries and is expected to publish initial results by 2005. The RISC study has three main...
Source: Obesity & Diabetes Week (2004-09-27)
|
